We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.59B
AUM Growth
+$680M
Cap. Flow
+$262M
Cap. Flow %
3.98%
Top 10 Hldgs %
67.98%
Holding
142
New
14
Increased
46
Reduced
57
Closed
13

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$47.5M
2
MSFT icon
Microsoft
MSFT
+$42.5M
3
TMO icon
Thermo Fisher Scientific
TMO
+$37.3M
4
ECL icon
Ecolab
ECL
+$36.9M
5
SBUX icon
Starbucks
SBUX
+$33.8M

Top Sells

Rank Stock Value
1
HDB icon
HDFC Bank
HDB
+$101M
2
PM icon
Philip Morris
PM
+$21.2M
3
META icon
Meta Platforms (Facebook)
META
+$11.4M
4
CELG
Celgene Corp
CELG
+$9.78M
5
MRK icon
Merck
MRK
+$8.94M

Sector Composition

Rank Sector Weight
1 Financials 26.2%
2 Healthcare 18.75%
3 Consumer Discretionary 17.75%
4 Communication Services 14.57%
5 Materials 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHC icon
76
Bausch Health
BHC
$1.68B
$3.41M 0.05%
197,010
-17,011
-8% -$204K
ONCE
77
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$3.12M 0.05%
52,281
+7,449
+17% +$416K
SUPN icon
78
Supernus Pharmaceuticals
SUPN
$2.73B
$3.09M 0.05%
71,670
-64,602
-47% -$2.3M
OXFD
79
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$3.06M 0.05%
182,148
+6,030
+3% +$90.1K
SIOX
80
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$3.05M 0.05%
16,438
+2,738
+20% +$480K
SPNC
81
DELISTED
Spectranetics Corp
SPNC
$2.81M 0.04%
73,180
+6,974
+11% +$201K
NDRM
82
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$2.77M 0.04%
+92,800
New +$2.4M
CEMP
83
DELISTED
Cempra, Inc.
CEMP
$2.73M 0.04%
592,946
-61,965
-9% -$245K
GWPH
84
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.72M 0.04%
27,098
+4,072
+18% +$438K
ITCI
85
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.71M 0.04%
217,962
+30,139
+16% +$349K
ACHC icon
86
Acadia Healthcare
ACHC
$2.63B
$2.67M 0.04%
+54,000
New +$2.39M
ACRS icon
87
Aclaris Therapeutics
ACRS
$722M
$2.62M 0.04%
96,600
+15,100
+19% +$411K
TVRD
88
Tvardi Therapeutics
TVRD
$22.5M
$2.54M 0.04%
4,584
-1,377
-23% -$874K
TD icon
89
Toronto Dominion Bank
TD
$195B
$2.44M 0.04%
37,332
– –
ELGX
90
DELISTED
Endologix Inc
ELGX
$2.44M 0.04%
50,101
-2,355
-4% -$139K
INSM icon
91
Insmed
INSM
$22.7B
$2.43M 0.04%
141,471
+19,021
+16% +$325K
MA icon
92
Mastercard
MA
$497B
$2.41M 0.04%
19,819
-8,481
-30% -$1.01M
HIND
93
Vyome Holdings
HIND
$14.5M
– –
0
– –
NEO icon
94
NeoGenomics
NEO
$2.03B
$2.2M 0.03%
+246,000
New +$1.95M
SNA icon
95
Snap-on
SNA
$21.4B
$2M 0.03%
12,677
+3,760
+42% +$615K
STOR
96
DELISTED
STORE Capital Corporation
STOR
$1.91M 0.03%
84,911
+19,915
+31% +$441K
CVS icon
97
CVS Health
CVS
$138B
$1.81M 0.03%
22,470
– –
ARMK icon
98
Aramark
ARMK
$15.1B
$1.7M 0.03%
+57,616
New +$1.58M
INGR icon
99
Ingredion
INGR
$6.47B
$1.63M 0.02%
13,700
– –
VLRX
100
DELISTED
VALERITAS HOLDINGS INC
VLRX
$1.6M 0.02%
+11,698
New +$1.36M
2 3
4
5 6

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q2 2017 Portfolio in Review

As of Q2 2017, C WorldWide Group held 142 positions worth $6.59B, up 12% from $5.91B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

C WorldWide Group deployed $262M of net new capital in Q2 2017, opening 14 new positions and adding to 46 existing holdings. Its largest new stake was Bristol-Myers Squibb: 267,012 shares worth $14.9M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was HDFC Bank, an estimated $101M trimmed.

  • C WorldWide Group's largest Q2 2017 buy was Bristol-Myers Squibb: 267,012 shares worth $14.9M.
  • C WorldWide Group added most to Visa in Q2 2017, an estimated $47.5M increase.
  • C WorldWide Group's biggest Q2 2017 reduction was HDFC Bank, cutting an estimated $101M.
  • C WorldWide Group fully exited Novadaq Technologies Inc. in Q2 2017, selling an estimated $3.86M.
  • C WorldWide Group's ten largest holdings make up 68% of its $6.59B portfolio in Q2 2017.
  • C WorldWide Group opened 14 new positions and closed 13 in Q2 2017.
  • C WorldWide Group's portfolio value rose 12% quarter-over-quarter to $6.59B.

Based on C WorldWide Group's 13F filing for Q2 2017, filed 2 Aug 2017.